PREDIDIAB PRÉDIRE POUR PRÉVENIR
LIVE

Serial Number

79419015

Owner

PrédiDiab

Attorney

Andrew D. Bochner

Filing Date

Jan 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PREDIDIAB PRÉDIRE POUR PRÉVENIR Trademark

Serial Number: 79419015 • Registration: 8226654

PREDIDIAB PRÉDIRE POUR PRÉVENIR is a trademark filed by PrédiDiab on January 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

PrédiDiab

1 rue Pierre Fontaine

Entity Type: 98

Trademark Details

Filing Date

January 17, 2025

Registration Date

April 28, 2026

Published for Opposition

March 10, 2026

Goods & Services

Scientific research, scientific investigations for medical purposes; technological consulting services for digital transformation new product development; industrial design; medical and pharmacological research services; development of pharmaceutical products for others; carrying out evaluations of pharmaceutical products being product quality evaluation services; carrying out testing on pharmaceutical products being product quality testing services; laboratory research services concerning pharmaceuticals; computer programming in the medical field; management of data for medical use being electronic data storage of medical data; information and advisory services relating to the aforesaid services; providing scientific research consultation and consultancy pertaining to pharmacology

Pharmaceutical and veterinary preparations for the treatment of diabetes; pharmaceutical and veterinary preparations, namely, medicinal preparations for regulating blood sugar and improving glucose metabolism, dietary supplements, dietetic food adapted for medical use, sanitary preparations for medical purposes; sanitary products for medicine being sanitary sterilizing preparations; dietetic foods and beverages adapted for medical use; chemical reagents for medical and pharmaceutical use; vaccines; food for babies; medical plasters, gauze for dressings; disinfectants; vitamins, vitamin-based preparations being dietary supplements; natural dietetic foods based on medicinal plants for medical and veterinary use; nutritionally fortified beverages and foods for medicinal use; additives in the nature of dietary supplements for humans and for animals for medicinal use; mineral food supplements for medicinal use; nutritional supplements, plant-based dietary supplements for medicinal use; food supplements containing proteins, carbohydrates, lipids, fibers, and micronutrients, for medical use; plant extracts other than essential oils for medicinal use; preparations for making dietetic and medicated beverages, namely, powdered nutritional supplement drink mix and concentrate; medicinal preparations, namely, preparations for the treatment of diabetes; chemical preparations for medicinal use being chemical reagents for medical purposes; substances for medicinal use being medicinal drinks; medicated candy and confectionery for medicinal use; medicated pharmacological preparations for skin care; medical diagnostic products being diagnostic preparations for medical purposes; kit for detecting a risk of predisposition to diabetes being diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; chemical preparations for the diagnosis of diabetes being diagnostic preparations for medical purposes; pharmaceutical preparations for the prevention and treatment of diabetes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 12, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 12, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 28, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 28, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Mar 5, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 18, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 17, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 13, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 12, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 13, 2025 REPR